American Federation for Aging Research - American Federation for Aging Research

Watch a video of Nir Barzilai at Metabesity 2017 on the Targeting Aging with Metformin (TAME) Trial
August 01, 2018 - (News) AFAR is pleased to share this video featuring Deputy Scientific Director and multiple-grantee Nir Barzilai, M.D. In the video, Dr. Barzilai discusses the Targeting Aging with Metformin (TAME) study, his research on centenarians and longevity, and the goal to extend healthspan. The presentation is framed around the topic of…
Board member in the News: Deputy Scientific Director Nir Barzilai and the TAME trial featured in Vox
August 17, 2018 - (News) On August 15, 2018, Netflix and Vox's “Explained” series premiered a new episode focusing on aging research and longevity; AFAR expert Nir Barzilai, MD lends insight on the promise of aging research and the Targeting Aging with Metformin (TAME) Trial, which AFAR helps manage. Dr. Barzilai is AFAR’s Deputy…
Board Member in the News: Nir Barzilai discusses importance of funding AFAR-managed TAME Trial to achieve FDA indication for aging
August 23, 2022 - (News) On August 9, 2022, STAT News shared insights from AFAR Scientific Director Nir Barzilai, MD, emphasizing the importance of funding the AFAR-managed TAME Trial to achieve an indication for aging from the Federal Food and Drug Administration (FDA). In addition to serving as AFAR’s Scientific Director, Dr. Barzilai is a…
Board Member in the News: Nir Barzilai highlights the potential benefits of therapeutic interventions and the AFAR-managed TAME Trial in BioWorld
July 29, 2022 - (News) On July 19, 2022, BioWorldfeatured insights from AFAR Scientific Director Nir Barzilai, MD, on the use of therapeutic interventions to expand healthspan and increase lifespan. Dr. Barzilai noted the upcoming AFAR-managed TAME Trials as an opportunity to research to benefits of one therapeutic, metformin. In addition to serving as AFAR’s…
AFAR Experts in the News: Austad and Barzilai in Fortune Well on metformin and the TAME Trial
May 17, 2023 - (News) On May 4, 2023, Fortune Well featured insights from AFAR Senior Scientific Director Steven Austad, PhD, and Scientific Director Nir Barzilai, MD, in an article on metformin’s potential to target the biology of aging and extend healthspan. Dr. Barzilai explains the need for the Targeting Aging with Metformin (TAME) Trial…
AFAR in the News: Steven Austad, Nir Barzilai, and James Kirkland discuss how the TAME Trial, senolytics, and gerotherapeutics can increase healthspan in The Washington Post
March 09, 2021 - (News) On March 6, 2021, The Washington Post featured insights from our Scientific leadership Steven N. Austad, PhD, Nir Barzilai, MD, and James L. Kirkland, MD, PhD, in a Health section cover story examining how senolytics and gerotherapeutics, such as metformin and rapamycin, can extend healthspan, or increase our years of…
Experts in the News: Rozalyn Anderson, Nir Barzilai, and James Kirkland on the hallmarks of aging, senescence, dietary timing, the TAME Trial and more on Stereo Chemistry podcast
April 12, 2021 - (News) On March 23, 2021, Stereo Chemistry, the official podcast of Chemistry & Engineering News, featured insights from several AFAR experts, including Rozalyn Anderson, PhD, Nir Barzilai, MD, and James Kirkland, MD, PhD. The AFAR experts highlighted recent advances in aging research to extend healthspan including senolytics, dietary timing, the hallmarks…
AFAR Leadership in the News: Scientific Director Nir Barzilai on gerotherapeutic and lifestyle interventions to extend healthspan on the CNN Chasing Life podcast with Dr. Sanjay Gupta
August 01, 2023 - (News) On August 1, 2023, the CNN podcast Chasing Life with Dr. Sanjay Gupta featured AFAR Scientific Director Nir Barzilai, MD. Dr. Barzilai shared insights on interventions aimed at extending healthspan including lifestyle and gerotherapeutics.In the episode ‘Biohacking...or BS?’, Dr. Barzilai explains the science behind how dietary timing, sleep, exercise, and…
AFAR in the News: SuperAgers Family Study, Principal Investigator Sofiya Milman, MD, and 100-year-old Study Participant Madeline Paldo featured on CNBC
September 25, 2023 - (News) On September 18, 2023, CNBC published an article on AFAR’s SuperAgers Family Study featuring insights from Principal Investigator and AFAR grantee Sofiya Milman, MD, MS, and 100-year-old Study participant Madeline Paldo on the secrets to living an exceptionally long and healthy life.In the article, participant Madeline Paldo cites several factors—including…
AFAR Expert in the News: AFAR SuperAgers Family Study Co-Investigator Thomas Perls, MD, in CNBC on genetics, lifestyle, and exceptional longevity
August 14, 2023 - (News) On August 14, 2023, CNBC featured insights from AFAR SuperAgers Family Study Co-Investigator Thomas Perls, MD, MPH, FACP, on the incredible longevity of centenarians Elizabeth Francis—the oldest woman living in Texas who celebrated her 114thbirthday last week. Dr. Perls also discusses the role of both lifestyle and genetics in the…

Page 4 of 13 pages